Staidson | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.23 |
Market Cap |
CNY5.68 B |
Shares Outstanding |
466.65 M |
Public Float |
155.74 M |
Address |
36 Jinghai 2nd Road Beijing Beijing 100176 China |
Employees | - |
Website | http://www.staidson.com |
Updated | 07/08/2019 |
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of independent intellectual property innovation drugs. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The company was founded on August 16, 2002 and is headquartered in Beijing, China. |